Revagenix
Revagenix is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat multidrug-resistant organisms. They are advancing a pipeline of antibiotic programs designed to treat infections caused by these organisms, addressing a critical unmet medical need. The company leverages a team of seasoned experts and strategic collaborations to develop next-generation antibiotic treatments.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount:
Date: 05-Jan-2024
Investors: Tenmile, Novo Holdings
Markets: Biopharmaceutical, Antibiotics, Biotechnology, Pharmaceutical, Service Industry
HQ: San Mateo, California, United States
Founded: 2019
Website: https://www.revagenix.com/
LinkedIn: https://www.linkedin.com/company/revagenix-inc
Crunchbase: https://www.crunchbase.com/organization/revagenix
Leave a Comment
Comments
No comments yet.